Index Performance
-6.74%
SCDI
+17.21%
IBB
+6.64%
DIA
+7.59%
QQQ
Overview
Description
To track the performance of clinical development organizations.
- TickerSCDI
- Inception Date05/31/2023
- WeightingEqual
- # of holdings12
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
Harvard Bioscience, Inc. (HBIO) | 9.32% | $145.49M | -18.23% | 54.83% | 2.07 |
Fortrea Holdings, Inc. (FTRE) | 9.26% | $2.41B | -13.36% | 12.99% | 1.72 |
Bio-Rad Laboratories, Inc. (BIO) | 8.83% | $9.00B | -9.75% | 53.45% | 3.69 |
IQVIA Holdings, Inc. (IQV) | 8.82% | $42.35B | 2.53% | 27.71% | 3.35 |
Charles River Laboratories International, Inc. (CRL) | 8.78% | $11.43B | -1.73% | 31.65% | 4.10 |
Thermo Fisher Scientific, Inc. (TMO) | 8.57% | $226.93B | -1.37% | 37.21% | 5.63 |
Evotec SE (EVO) | 8.49% | $1.67B | N/A | 16.65% | 3.45 |
Veeva Systems, Inc. (VEEV) | 8.29% | $30.16B | 23.56% | 73.26% | 11.23 |
ICON plc (ICLR) | 8.08% | $25.89B | 4.95% | 22.49% | 3.51 |
Medpace Holdings, Inc. (MEDP) | 7.52% | $11.80B | 14.59% | 27.76% | 6.33 |
CryoPort, Inc. (CYRX) | 7.23% | $441.35M | -13.09% | 31.83% | 3.83 |
West Pharmaceutical Services, Inc. (WST) | 6.81% | $20.19B | -6.92% | 32.95% | 8.39 |
Market data by FactSet